Author

Bobak Parang

Institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Wexner Medical Center, The Ohio State University

Observed institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Wexner Medical Center, Weill Cornell Medicine, The Ohio State University

ORCID: 0000-0002-7411-0670

Observed ORCID: 0000-0002-7411-0670

OpenAlex ID: A5027851702

Direct sensing of dietary ω-6 linoleic acid through FABP5-mTORC1 signaling

2025 · Nikos Koundouros, Michal J. Nagiec, et al. · Science · 41

Second‐Line Therapy Following Osimertinib in Metastatic EGFR ‐Mutated Non‐Small‐Cell Lung Cancer at an Academic Medical Center

2026 · Michael Rafizadeh, Stephanie Bogdan, et al. · Cancer Reports

PP01.26: Real-World Time Toxicity of Tarlatamab in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

2026 · Jinesh Gheeya, Athanasios Papadas, et al. · Journal of Thoracic Oncology

Abstract 7039: FER drives drug-tolerant persister cell survival in EGFR-mutant lung cancer.

2026 · Bobak Parang, Rabia Khan, et al. · Cancer Research

CLO26-114: Association Between Neoadjuvant Chemoimmunotherapy-Induced Anemia and Survival in Patients With Resectable Non-Small Cell Lung Cancer

2026 · Jennifer D. Hwang, Po-Lan Su, et al. · Journal of the National Comprehensive Cancer Network

CLO26-084: Prognostic Value of Sarcopenia in Patients With Metastatic NSCLC Receiving First-Line Immune Checkpoint Inhibitors

2026 · Nikhil Sekar, Songzhu Zhao, et al. · Journal of the National Comprehensive Cancer Network

Propionate metabolism is dysregulated in non-small cell lung cancer patients and EGFR-mutant drug-tolerant persister cells

2026 · Bobak Parang, Liron Yoffe, et al. · Scientific Reports

The impact of preoperative imaging strategies in EGFR-mutant non-small cell lung cancer: a multicenter retrospective review

2025 · Jonathan W. Lee, Michael Rafizadeh, et al. · medRxiv

Propionate metabolism dysregulation promotes drug-tolerant persister cell survival in non-small cell lung cancer

2025 · Bobak Parang, Liron Yoffe, et al. · bioRxiv (Cold Spring Harbor Laboratory)

The impact of preoperative imaging strategies in EGFR-mutant non-small cell lung cancer (NSCLC): A multi-center retrospective review.

2025 · Jonathan W. Lee, Michael Rafizadeh, et al. · Journal of Clinical Oncology

Abstract 3175: Methylmalonic acid in TME signaling

2022 · Vivien Low, Zhongchi Li, et al. · Cancer Research

Works count: 11

Citation count: 41

H-index: 1

I10-index: 1